HC Wainwright Weighs in on Oklo’s Q1 Earnings (NYSE:OKLO)

Oklo Inc. (NYSE:OKLOFree Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Oklo in a research report issued on Wednesday, March 18th. HC Wainwright analyst S. Joshi anticipates that the company will post earnings per share of ($0.19) for the quarter. HC Wainwright currently has a “Buy” rating and a $90.00 target price on the stock. The consensus estimate for Oklo’s current full-year earnings is ($8.20) per share. HC Wainwright also issued estimates for Oklo’s Q2 2026 earnings at ($0.21) EPS and FY2030 earnings at $2.10 EPS.

Several other analysts also recently issued reports on the stock. Craig Hallum reiterated a “hold” rating on shares of Oklo in a research report on Wednesday. Weiss Ratings restated a “sell (d)” rating on shares of Oklo in a research report on Thursday, January 22nd. The Goldman Sachs Group reduced their target price on Oklo from $91.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday. Citigroup lowered their target price on Oklo from $95.00 to $73.50 and set a “neutral” rating on the stock in a report on Wednesday. Finally, Needham & Company LLC dropped their price target on Oklo from $135.00 to $73.00 and set a “buy” rating for the company in a research report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $86.63.

View Our Latest Stock Analysis on OKLO

Oklo Trading Down 3.4%

NYSE:OKLO opened at $54.80 on Thursday. The company has a market capitalization of $9.51 billion, a P/E ratio of -76.11 and a beta of 0.80. The firm has a 50-day moving average price of $73.41 and a two-hundred day moving average price of $94.73. Oklo has a twelve month low of $17.42 and a twelve month high of $193.84.

Oklo (NYSE:OKLOGet Free Report) last released its quarterly earnings data on Tuesday, March 17th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same period last year, the firm posted ($0.74) EPS.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Armstrong Advisory Group Inc. purchased a new stake in shares of Oklo in the third quarter valued at $27,000. Gables Capital Management Inc. purchased a new position in Oklo during the third quarter worth about $28,000. Nemes Rush Group LLC acquired a new stake in Oklo in the 3rd quarter worth about $28,000. CI Investments Inc. boosted its stake in Oklo by 153.0% in the 3rd quarter. CI Investments Inc. now owns 296 shares of the company’s stock worth $33,000 after buying an additional 179 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. purchased a new stake in Oklo in the 3rd quarter valued at about $33,000. 85.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Oklo

In other news, CFO Richard Craig Bealmear sold 72,090 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $60.00, for a total value of $4,325,400.00. Following the completion of the transaction, the chief financial officer owned 386,008 shares of the company’s stock, valued at $23,160,480. The trade was a 15.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jacob Dewitte sold 72,960 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $60.00, for a total transaction of $4,377,600.00. Following the transaction, the chief executive officer directly owned 751,533 shares in the company, valued at $45,091,980. The trade was a 8.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 2,062,424 shares of company stock worth $169,888,312 over the last ninety days. 18.90% of the stock is currently owned by corporate insiders.

Key Stories Impacting Oklo

Here are the key news stories impacting Oklo this week:

  • Positive Sentiment: Regulatory and DOE approvals materially de-risk commercialization plans — Oklo’s Atomic Alchemy unit secured an NRC materials license and the DOE approved a Nuclear Safety Design Agreement for its Groves Isotopes Test Reactor, opening an early isotope revenue pathway. Atomic Alchemy DOE approval
  • Positive Sentiment: DOE partnership and pilot-project momentum — Oklo signed a deal to build a reactor at Idaho National Lab and has NSDAs under the Reactor Pilot Program, moving the company from concept toward execution and potential early cash from isotopes. DOE Idaho National Lab deal
  • Positive Sentiment: Analyst buy-side conviction and institutional accumulation support upside — Several firms reaffirmed coverage or maintained Buy/Overweight ratings and MarketBeat highlights rising institutional ownership and a bullish technical setup that could compress float and amplify rallies. MarketBeat analysis
  • Neutral Sentiment: Analyst forecasts point to long runway — HC Wainwright reiterates a Buy and models near-term losses (Q1/Q2 2026 EPS estimates negative) but projects profitability by 2030, signaling industry optimism tempered by multi-year execution risk. (HC Wainwright research)
  • Neutral Sentiment: Mixed broker targets — Several broker reports raised or reaffirmed targets even as others trimmed theirs, leaving consensus upside but wider dispersion in near-term expectations. Example coverage roundup: Broker target roundup
  • Negative Sentiment: Q4 earnings miss and widening loss pressured the stock — Oklo reported Q4 EPS of ($0.27) vs. consensus ($0.17), prompting short-term selling as the company remains pre-revenue and capital-intensive. Earnings and regulatory update
  • Negative Sentiment: Analyst target cuts and headline volatility — Several firms trimmed price targets (Goldman, Citi and others), increasing near-term uncertainty and headline-driven trading. Coverage of the repricing and market reaction: Analyst cuts and market reaction
  • Negative Sentiment: Insider selling heightened concern — Recent filings show the CFO sold shares worth several million dollars, which amplifies short-term downward pressure and investor caution. Insider sale report

About Oklo

(Get Free Report)

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.

Featured Articles

Earnings History and Estimates for Oklo (NYSE:OKLO)

Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.